NEW

Siemens Healthineers to Acquire Varian

Siemens Healthineers AG and Varian Medical Systems Inc. have entered into an agreement, pursuant to which Siemens Healthineers shall acquire all shares of Varian for $177.50 per share in cash. This corresponds to a purchase price of approximately $16.4 billion....

MTMI Partners with Nautilus Medical Technologies

The Medical Technology Management Institute (MTMI), a division of The College of Health Care Professions, has announced a partnership with Nautilus Medical Technologies, developer of a cloud-based imaging sharing platform used by over a thousand health care providers...

Gillette Children’s Specialty Healthcare is the first U.S. hospital to image patients with EOSedge

EOS imaging, a provider of 2D/3D orthopedic medical imaging and software solutions for 3D anatomical modeling and surgical planning, has announced the first exams performed with EOSedge in the United States, at Gillette Children's Specialty Healthcare’s main campus...

Webinar on FDA’s Regulation of Face Masks and Surgical Masks during the COVID-19 Pandemic

On Tuesday, August 4, 12:00 p.m.-1:00 p.m. ET, the U.S. Food and Drug Administration (FDA) will host a webinar on the FDA’s regulation of face masks and surgical masks during the COVID-19 pandemic. This webinar will expand the scope of the respirator webinar series to...

Zebra Medical Vision Secures its First FDA Clearance in Oncology

Zebra Medical Vision, the deep-learning medical imaging analytics company, has announced its sixth FDA 510(k) clearance for its mammography solution, HealthMammo, which has already received a CE mark. Zebra Medical’s algorithm empowers breast radiologists by prioritizing and identifying suspicious mammograms, providing a safety net for radiologists. The suspicious mammograms are identified faster and read earlier than the current “first-in first-out” standard of care.

This is Zebra Medical Vision’s first solution for oncology to receive FDA clearance, as part of the company’s AI1 “All-In-One” bundle. Zebra Medical is also the first startup to receive FDA clearances for AI-based technology across three imaging modalities – CT, X-ray and mammography, providing coverage for roughly 80% of the total imaging volumes.

Zebra Medical’s HealthMammo solution is an automatic AI tool that indicates “suspicious” or “not suspicious” for every 2D mammography performed. The mammograms are automatically sent to Zebra Medical’s imaging analytics platform, where they are processed and analyzed for suspected breast lesions. The HealthMammo product then returns its result to the radiologist, either by signaling within the worklist or by notifying the user in a dedicated application.

The algorithm can be used in single reader paradigms, supporting triage and workflow improvement (as cleared by the FDA) or in double reading paradigms, already available outside of the U.S., supporting the second radiologists and reducing their workload.

Supporting early detection protocols, Zebra Medical Vision’s HealthMammo product helps health providers minimize the COVID-19-induced care gaps with an automated AI tool that can identify faster patients with suspicious lesions. According to the FDA Mammography Quality Standards program (MQSA), approximately 40 million mammograms are performed in the U.S. every year. With the outbreak of coronavirus, annual mammography tests during lockdown were postponed or canceled. As a result, providers are dealing with substantial growing backlogs, as 100,000 screens are added every day in the US alone, in addition to a 94% drop in mammography imaging volumes during lockdown. Patients are experiencing increasing anxiety waiting to be tested and run the risk of missing the early detection component of annual screening which could result in an undetected cancer that keeps growing.

“As restrictions are lifted from the COVID-19 crisis, the backlog of mammograms has increased,” says Dr. Michael Fishman, breast imaging section chief at Boston Medical Center (BMC), Massachusetts. “Zebra Medical Vision’s HealthMammo may help radiologists deal with the screening management strategy of the post COVID backlog and triaging.”

Previous

Next

Submit a Comment

Your email address will not be published. Required fields are marked *